XCF Global, Inc. (SAFX): Nasdaq/NYSE listing notice — Nasdaq warns XCF Global of potential delisting over delayed Q2 10-Q filing

XCF Global, Inc.

Received Nasdaq notice on Aug 21, 2025 for noncompliance with Rule 5250(c)(1) due to late Q2 Form 10-Q.
Has 60 days (until Oct 20, 2025) to submit a plan; Nasdaq can grant up to 180-day extension (to Feb 17, 2026).
Expects to file Q2 10-Q by Sept 30, 2025; stock continues trading under SAFX with ~153.2M shares outstanding.
Notice has no immediate impact on business operations or debt agreements.
Company is a sustainable aviation fuel producer; free float below 20%.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

XCF Global, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

August 21, 2025, XCF Global, Inc. (the “Company”) was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was no longer compliant with Nasdaq rule 5250(c)(1) due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “Q2 Form 10-Q”). Under Nasdaq rules, XCF has 60 calendar days, or until October 20, 2025, to submit a plan to regain compliance. If XCF’s plan is accepted, Nasdaq can grant an exception of up to 180 calendar days from the due date of the Q2 Form 10-Q, or until February 17, 2026, to regain compliance. The notice ha

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

XCF Global, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-025565

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.